GlassScriptPhysician profile
Heather L Steele
NPI 1194256065
$7,675.98
in general payments reported to CMS, 2019-2025
29 companies · $2,137 in 2025
The $2,137 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $560 · 2022: $1,394 · 2023: $1,994 · 2024: $1,590 · 2025: $2,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,307 · Education: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,307.25 |
| Education | $413.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,224.11 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $973.91 | 2021-2025 | |
| Leo Pharma INC. | $808.11 | 2021-2025 | Adbry, Anzupgo, Spevigo |
| Genzyme Corporation | $554.16 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $553.33 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $346.89 | 2021-2025 | Dupixent |
| Pfizer INC. | $333.41 | 2021-2025 | |
| Amgen INC. | $316.46 | 2021-2025 | Otezla, Otezla |
| Ucb, INC. | $310.97 | 2021-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $250.40 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $232.10 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Dermavant Sciences, INC. | $223.49 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $221.05 | 2023-2025 | Nemluvio, Oracea, Aklief |
| Sanofi-Aventis U.S. LLC | $196.98 | 2023-2025 | |
| Incyte Corporation | $196.67 | 2021-2025 | Opzelura |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $163.74 | 2022-2025 | Absorica Ld, Winlevi, Ilumya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.23 | 2022-2025 | Cabtreo, Arazlo, Jublia |
| Arcutis Biotherapeutics, INC. | $102.73 | 2023-2025 | Zoryve |
| Organon LLC | $101.86 | 2024-2025 | Vtama, Hadlima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.48 | 2023-2024 | Spevigo, Cyltezo |
| Almirall LLC | $89.86 | 2021-2025 | Seysara, Klisyri |
| Fresenius Kabi USA, LLC | $63.46 | 2023-2024 | Idacio |
| Paratek Pharmaceuticals, INC. | $35.36 | 2021-2025 | Nuzyra |
| Verrica Pharmaceuticals INC. | $24.18 | 2023 | Ycanth |
| Sebela Pharmaceuticals INC. | $23.90 | 2022 | |
| Nabriva Therapeutics, Plc | $23.47 | 2022 | |
| Glaxosmithkline, LLC. | $22.67 | 2023 | Arexvy, Shingrix |
| Kyowa Kirin, INC. | $19.70 | 2022 | |
| Lnhc, INC | $19.30 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.